Clinical trial
Electroporation Therapy With Bleomycin in Treating Patients With Pancreatic…
NCT00027521 · Ichor Medical Systems Incorporated, Industry · Withdrawn
Key facts
| NCT number | NCT00027521 |
|---|---|
| Title | Electroporation Therapy With Bleomycin in Treating Patients With Pancreatic Cancer |
| Official title | Phase I Study: Electroporation Therapy With Bleomycin For The Treatment Of Pancreatic Cancer |
| Lead sponsor | Ichor Medical Systems Incorporated, Industry |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Withdrawn |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer |
| Intervention type | Biological, Drug |
| Interventions | bleomycin sulfate, electroporation therapy |
| Enrollment | 0 |
| Start date | Dec 1, 2000 |
| First posted | Nov 21, 2003 |
| Last update posted | Sep 19, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: